Septic arthritis in Iceland 1990-2002: increasing incidence due to iatrogenic infections by Geirsson, A J et al.
doi:10.1136/ard.2007.077131 
 2008;67;638-643; originally published online 27 Sep 2007; Ann Rheum Dis
  
Á J Geirsson, S Statkevicius and A Víkingsson 
  
 incidence due to iatrogenic infections
Septic arthritis in Iceland 19902002: increasing
 http://ard.bmj.com/cgi/content/full/67/5/638
Updated information and services can be found at: 
 These include:
 References
  
 http://ard.bmj.com/cgi/content/full/67/5/638#BIBL
This article cites 36 articles, 12 of which can be accessed free at: 
 Open Access This article is free to access 
Rapid responses
 http://ard.bmj.com/cgi/eletter-submit/67/5/638
You can respond to this article at: 
 service
Email alerting
the top right corner of the article 
Receive free email alerts when new articles cite this article - sign up in the box at
 Notes   
 http://journals.bmj.com/cgi/reprintform
To order reprints of this article go to: 
 http://journals.bmj.com/subscriptions/
 go to: Annals of the Rheumatic DiseasesTo subscribe to 
 on 4 June 2008 ard.bmj.comDownloaded from 
Septic arthritis in Iceland 1990–2002: increasing
incidence due to iatrogenic infections
A´ J Geirsson, S Statkevicius, A Vı´kingsson
Department of Medicine,
Landspitali University Hospital of
Iceland
Correspondence to:
A´ J Geirsson, Department of
Medicine, Landspitali Fossvogi,
University Hospital of Iceland,
108 Reykjavı´k, Iceland; arnijon@
landspitali.is
Accepted 17 September 2007
Published Online First
27 September 2007
This paper is freely available
online under the BMJ Journals
unlocked scheme, see http://
ard.bmj.com/info/unlocked.dtl
ABSTRACT
Objectives: To assess the impact of increased number of
diagnostic and therapeutic joint procedures on the
incidence and type of septic arthritis (SA).
Methods: All cases of SA in Iceland from 1990–2002
were identified by thorough review of the available
medical information. The results of synovial fluid cultures
from every microbiology department in Iceland were
checked and positive culture results reviewed, as well as
patient charts with a discharge diagnosis of septic
arthritis (International Statistical Classification of Diseases
and Related Health Problems (ICD) code M009).
Results: A total of 253 cases of SA (69 children and 184
adults) were diagnosed in Iceland in 1990–2002, giving
an average incidence of 7.1 cases/100 000 inhabitants.
The incidence of SA increased from 4.2 cases/100 000 in
1990 to 11.0 cases/100 000 in 2002. This rise in SA was
primarily observed in adults where the incidence rose by
0.61 cases/100 000 per year (p,0.001). SA was
iatrogenic in 41.8% of adults and the number of iatrogenic
infections increased from 2.8 cases/year in 1990–1994 to
9.0 cases/year in 1998–2002 (p,0.01). The annual
number of arthroscopies increased from 430 in 1990–
1994 to 2303 in 1998–2002 (p,0.001) and there was a
correlation between the total usage of intra-articular
drugs in Iceland and the incidence of SA (p,0.01). The
frequency of post-arthroscopy SA was 0.14% and post-
arthrocentesis SA 0.037%.
Conclusions: The incidence of SA has increased in
recent years due to an increased number of arthroscopies
and joint injections. Although the frequency of SA per
procedure has not changed, these results emphasise the
importance of sterile technique and firm indications for
joint procedures.
Septic arthritis (SA) due to bacterial infection is a
serious and potentially life threatening disease that
can lead to rapid destruction of the vulnerable
articular hyaline cartilage and irreversible loss of
joint function.1 2 The reported incidence of septic
arthritis is 2–6 cases/100 000 inhabitants.3–7
Advancing age, rheumatoid arthritis (RA), osteoar-
thritis, immunosuppressive therapies and diabetes
mellitus have been identified as the main risk
factors for idiopathic septic arthritis. Iatrogenic
infection resulting from joint surgeries, arthrosco-
pies and needle insertions into joints is another
source of septic arthritis. In recent years, the
number of arthroscopies has greatly increased as
well as the number of joint injections due to the
emergence of intra-articular viscosupplementation
therapies. The risk of procedure-related SA has
been estimated at 0.5–2.0% for arthroscopies8–12
and 0.005–0.0002% for joint injections.13–15 In light
of the growing number of individuals with one or
more risk factors for SA, the incidence would be
expected to be rising. However, very few of these
studies have addressed this issue and most pub-
lished studies are derived from selected popula-
tions. Therefore a retrospective, nationwide study
was carried out to examine the incidence, cause
and characteristics of septic arthritis in Iceland over
a 13-year period.
MATERIALS AND METHODS
Clinical setting and definition of cases
Over a 13-year period from 1 January 1990 to 31
December 2002 a nationwide computerised and
manual survey for culture positive joint fluids was
performed in all microbiology laboratories in
Iceland. In addition, medical records and archives
at all hospitals that admit patients with SA were
searched for the discharge diagnosis of bacterial
arthritis (M009 according to the International
Statistical Classification of Diseases and Related
Health Problems (ICD)-9 and ICD-10 codes).
Data collection
Hospital medical records were reviewed and
clinical and laboratory data collected in a systema-
tic manner. Iatrogenic SA was defined as occurring
within 2 weeks after arthrocentesis or arthroscopy,
or within 6 months after open joint surgery. The
total number of arthroscopic and arthrocentesis
procedures 1990–2002 were available from compu-
terised records at the State Social Security Institute
(SSI), which is the only agency in Iceland that
reimburses for ambulatory medical procedures.
The total import and sales of corticosteroids for
intra-articular injections (methyl prednisolone
(DepoMedrol; Pfizer NewYork, NewYork, USA),
betamethasone (Diprospan; Schering-Plough,
Kenilworth, New Jersey, USA) and triamcinolone
(Lederspan; Meda AB, Solna, Sweden)) and for
hyaluronic acid preparations (Hyalgan, Artzal
Astra-Zeneca, Albertslund, Denmark) were simila-
rily obtained from the SSI. Defined daily doses
(DDD) for all drugs were obtained from the World
Health Organization (WHO) Collaborating Centre
for Drug Statistics Methodology (WHOCC). The
study was approved by the Data Protection
Authorities in Iceland and the National Bioethics
Committee.
Statistical methods
The age-specific incidence of infectious arthritis
during the period 1990–2002 (yearly and total) was
obtained by dividing the number of cases by the
mean population number for each gender in
each 10-year age interval (the first 2 years and 2–
9 years of life were computed separately).
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The age-standardised incidence was computed using the global
population figure as reference. The same approach was used for
obtaining the standardised values for ages 0–16 and .16 years
using a truncated global population figure as reference.
Regression analysis was performed for the age-standardised
incidence for each gender. Linear regression was first used for
finding the linear time trend and then quadratic regression was
used to find whether the time trend was changing with time.
The association of yearly use of intra-articular drugs (DDD/
1000 inhabitants) and number of septic arthritis cases was
analysed with linear regression with and without adjusting for
common time trend.
The same approach was used for analysing the association of
number of procedures involving joints and the number of septic
arthritis cases during the period 1990–2002. The level of
significance used was p,0.05. All tests were two-tailed. The
x2 test with Yates correction for continuity was used for
comparison between two groups using SigmaStat for Windows
software, V.3.11 (SigmaStat, Systat Software GmbH, Erkath,
Germany).
RESULTS
Incidence of septic arthritis
From 1990 to 2002 a total of 253 cases of bacterial arthritis were
diagnosed in Iceland, of which 159 were males and 94 females,
giving an average incidence of 7.1 cases/100 000 inhabitants.
Additionally, five cases of atypical mycobacterial joint infec-
tions were identified. These cases were not included in the
overall analysis of SA. There were 69 children (0–16 years old)
diagnosed with SA, 37 of those less than 2 years of age. Figure 1
shows age- and gender-specific incidence rates of SA for children
0–24 months old, >2–10 years old and subsequent 10-year age
groups. As shown in fig 1, women had lower incidence rates
than men in all age groups (male/female ratio 1.7). For both
sexes, the rate of SA rose sharply after the age of 50. Among
children less than 2 years of age the age adjusted incidence was
quite high at 27/100 000.
Change in the incidence of septic arthritis 1990–2002
The annual total number of cases of SA for children 0–16 years
and for adults are shown in fig 2. The annual incidence of SA
increased progressively from 4.2 per 100 000 in 1990 to 11.0 per
100 000 inhabitants in 2002. This change was primarily due to
increased number of SA cases in adults and was statistically
significant by linear trend, which showed a yearly increase of
0.61 adult cases per 100 000 (p,0.001). The mean annual
incidence during the first 5 years (1990–94) increased from 4.2
cases per 100 000 adult inhabitants to 9.4 per 100 000 adults in
1998–2002 (95% CI 3.2–5.5 and 7.9–11.1, respectively; p,0.01).
Iatrogenic septic arthritis
Joint infections were iatrogenic in 1.4% (1/69 cases) of children
and 41.8% (77/184 cases) of adults. Iatrogenic infections in
adults were due to open joint surgery in 26 cases (14.1% of
total), arthroscopy in 18 cases (9.8%) and arthrocentesis in 33
cases (17.9%) (table 1). The mean number of iatrogenic
infections increased from 2.8 infections/year in 1990–1994 to
9.0 infections/year in 1998–2002 (p,0.01) and this was the
main reason for the observed increase in SA during the study
period. The overall percentage of iatrogenic infections was
similar in young adults (age 17–65) and older adults (age >65).
Septic arthritis due to arthrocentesis was common in both age
groups but post arthroscopy SA was primarily observed in the
younger adults (15/101 vs 3/83; p = 0,02) whereas infections
due to open surgery were more common in the older adults (18/
83 vs 8/101; p = 0.01).
To determine whether the rising incidence of SA was related
to increased number of diagnostic or therapeutic joint proce-
dures, information about the total number of arthroscopies and
arthrocentesis were obtained from the SSI in Iceland (table 2).
The annual number of documented arthrocentesis was only
available for the practice of rheumatology and orthopaedics, but
not for general practitioners. We were, however, able to retrieve
accurate information about the annual sales of intra-articular
glucocorticoid and hyaluronan preparations for 1990–2002.
There was a correlation between the usage of intra-articular
betamethasone (DiprospanH; p = 0.001), hyaluronic acid
(p = 0.02), and the total usage of intra-articular drugs
(p = 0.008) and the incidence of SA (table 2). The number of
reimbursed arthrocentesis procedures performed by rheumatol-
ogists and orthopaedists did not change markedly over the
study period, but the number of arthroscopies increased from an
annual mean of 430 arthroscopies in 1990–1994 to 2303
arthroscopies in 1998–2002 (p,0.001).
Clinical and microbiological characteristics of septic arthritis
The clinical characteristics of SA in children (0–2 years vs.2–16
years old) and adults (16–65 years vs .65 years old) are shown
in table 3. No significant difference in joint distribution was
observed between younger and older adults, although shoulder
infections appeared to be more common in the elderly (13.8% vs
4.8%, p = 0.05). In adults, SA was polyarticular in 3.3% of cases.
Compared to adults the relative occurrence of SA of the hip
was significantly higher in children (35.5% vs 13.7% respec-
tively, p,0.001).
The median temperature on admission was 38–38.1uC in all
age groups. Normal temperatures (,37.8uC) were quite
frequent, seen in about one fourth of children and almost half
of the adults (table 3). Similarily, peripheral white blood cell
(WBC) count was normal (,10 000/ml) on admission in 26% of
children and 46% of adults. Normal values for temperature and
WBC count on admission were more common in adults
(p = 0.066 and p = 0.05 respectively). Normal erythrocyte
sedimentation rate (ESR) and C-reactive protein (CRP) values
were infrequent and only 2.3% of children and 4.4% of adults
had normal values for ESR and CRP on admission.
Synovial fluid was obtained in 97.4% of cases (98.6% of
children, 97.3% of adults). Results from synovial fluid analysis
are shown in table 3. Although the leukocyte count was
markedly elevated (median = 58 100/mm3) a relatively low
Figure 1 Age and gender specific incidence rates of septic arthritis for
children 0–24 months, 2–9 years old and subsequent 10-year age
groups.
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synovial fluid leukocyte count (,20 000/mm3) was observed in
7% of children and 15% of adults. Synovial fluid culture was
positive in 84% of adults but only in 54% of children. Blood
cultures were obtained in 96% (66/69) of children and in 74%
(137/184) of adults. They were positive in one quarter to one
third of individuals tested, arguably more often in the elderly
(41%, p = 0.056). Positive Gram stain and/or blood culture
increased the positively identified septic arthritis cases con-
siderably, from 54% to 61% in children and from 84% to 88% in
adults. The yield of synovial fluid culture was significantly
lower in adult patients who had received antibiotics prior to
diagnostic joint aspiration (10/27 negative, 37%) compared to
patients without antibiotic exposure (15/119 negative, 12.6%;
p = 0.002).
The contributing risk factors for SA among adults were
history of a recent trauma to the involved joint in 24% of cases,
osteoarthritis in 19%, diabetes mellitus (DM) in 7% all having
type II DM and being treated with per oral hypoglycaemic
drugs, rheumatoid arthritis in 4% all being treated with
methotrexate, neoplasia in 2% and one patient was HIV
positive. Additionally, three patients were receiving glucocorti-
coids. In 16 (8.7%) of the adult cases SA was due to infected
prosthetic joints, 12 knees, 3 hip joints and 1 shoulder joint.
The type and frequency of bacterial organisms is shown in
table 4.
A total of 33 of the adult cases were not identified by positive
joint fluid culture, and of those, 4 had positive Gram stain of
joint fluid and 4 had positive blood cultures. In all, 32 (46%)
children were not identified by positive joint fluid culture, but
one of those had positive Gram stain of joint fluid and three had
positive blood culture. The clinical and laboratory character-
istics of children and adults with SA diagnosed without positive
joint fluid culture was similar to the culture positive SA.
Specifically, median age, sex and joint involvement were
comparable, as well as ESR, CRP and synovial fluid leukocyte
count, duration of antibiotic therapy and hospital stay (data not
shown).
Of the 254 patients, 5 died in the hospital, (mean age, 70
years); 3 following infection with Staphylococcus aureus, 1 after
pneumococcal infection, and 1 following streptococcal infec-
tion. The mortality rate was 1.8% when calculated from all
cases of septic arthritis but 2,7% if limited to the adult
population.
From 1990–2002 we identified five cases of arthritis due to
mycobacteria other than tuberculosis; two Mycobacterium
kansasii, two Mycobacterium avium-intracellulare and one
Mycobacterium marinum infection. These infections affected
three elbows and two wrists joints in four men and one
woman, 34–49 years old. One of these patients was HIV
positive but the other four had no identifiable immunodefi-
ciency. These mycobacterial infections were not included in the
overall analysis of the data.
DISCUSSION
In this paper we report a markedly increased rate of joint
infections in adults in Iceland from 1990 to 2002. During the
study period there was a mean annual increase of 0.61 cases/
100 000 adult inhabitants. The incidence of 4.2 cases/100 000
adults in 1990–1994 is similar to the reported number in other
studies3–6 16 but the incidence of 9.4/100 000 adults during 1998–
2002 is considerably higher and statistically different (p,0.01).
This change is primarily due to increase in iatrogenic infections
following joint arthroscopies and arthrocentesis. It coincides
with marked increase in the registered number of joint
arthroscopies in Iceland and increased use of intra-articular
steroids and joint-viscous supplements in Iceland during these
years. However, this increase in SA following joint injections
was not due to a higher number of arthrocentesis procedures
performed by rheumatologists and orthopaedists. However, the
increased use of intra-articular steroids and joint-viscous
supplements suggests that the number of arthrocentesis
procedures did indeed increase during this observational period.
Figure 2 The annual total number of cases of septic arthritis for
children 0–16 years and adults.
Table 1 Iatrogenic septic arthritis in Iceland 1990–2002
Arthrocentesis Arthroscopy Open joint surgery Total
No. of cases 33 18 26 77
Age (median) 63 47 70 60.1
Male/female ratio 2 17 1 2.1
Infected joint:
Knee 64% (21) 89% (16) 62% (16) 69%
Shoulder 12% (4) 11% (2) 16% (4) 13%
Hip 3% (1) 0 16% (4) 6%
Other 21% (7) 0 8% (2) 12%
Synovial culture:
Coagulase-positive Staphylococci 49% (16) 22% (4) 27% (7) 35%
Coagulase-negative Staphylococci 21% (7) 28% (5) 20% (5) 22%
Streptococci 9% (3) 11% (2) 27% (7) 16%
Other 9% (3) 17% (3) 15% (4) 13%
Negative 12% (4) 22% (4) 11% (3) 14%
Figures in parentheses are absolute no. of cases.
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That scenario could be explained by higher numbers of
arthrocentesis procedures being performed by other doctors.
This is however purely speculative, since computerised doc-
umentation of arthrocentesis in primary care is mostly
unavailable. Septic arthritis due to open joint surgeries did not
increase over this time period.
The frequency of post-arthroscopic SA has been reported 0.1–
0.5% at specific medical centres9–12 but to our knowledge this
frequency has not been previously estimated based on a
nationwide analysis. The estimated frequency in Iceland of
0.14% is similar to these previous reports.
There is very limited data available in the medical literature
about the actual risk of SA following arthrocentesis. In early
reports this risk was estimated at 0.005 to 0.0002% per
arthrocentesic procedure.13–15 These percentages are lower than
can be estimated from our study. According to the SSI registry
in Iceland the total number of documented ambulatory
arthrocentesis in Iceland performed by rheumatologists and
orthopaedists is 6900 per year (table 2). Additionally, an
estimated maximum of 1000 arthrocentesis procedures are
performed annually by general practitioners (L. O´lafsson, the
Center of Health Care in Reykjavik, Iceland personal
communication). Accordingly, the estimated risk of septic
arthritis following arthrocentesis in Iceland is 3 infections/
7900 procedures, or 0.037% per injection. Compared to other
commonly performed procedures, an incidence of 0.037% per
injection is not high. However, given the significant morbidity
and 10–15% mortality previously reported in SA3–6 16 it is of
Table 2 The annual sales of intra-articular glucocorticoids and hyaluronans defined by DDD (defined daily dose) and the annual registered number of
arthroscopies and arthrocentesis in Iceland
Year Population No. cases Lederspan DepoMedrol Diprospan Hyaloronan Total Arthroscopy Arthrocentesis
1990 254 788 11 0.33 0.27 0.26 0.00 0.86 55 5829
1991 257 965 15 0.25 0.29 0.30 0.00 0.84 230 6253
1992 264 103 10 0.31 0.30 0.23 0.00 0.84 258 6808
1993 263 783 17 0.36 0.28 0.19 0.00 0.83 642 6612
1994 266 006 8 0.45 0.25 0.17 0.01 0.83 965 6404
1995 267 380 18 0.44 0.25 0.22 0.02 0.93 2245 6607
1996 268 927 16 0.46 0.24 0.20 0.07 0.97 3123 7558
1997 270 935 16 0.13 0.42 0.41 0.12 1.08 2847 8124
1998 273 764 26 0.39 0.25 0.40 0.17 1.21 1479 8297
1999 277 184 20 0.42 0.22 0.35 0.20 1.19 2157 8412
2000 281 154 27 0.40 0.22 0.28 0.22 1.12 2351 7551
2001 285 054 34 0.20 0.34 0.48 0.16 1.18 2795 7063
2002 287 559 36 0.00 0.33 0.61 0.12 1.06 2735 6891
Table 3 Clinical and laboratory characteristics of children and adults with septic arthritis in Iceland 1990–2002
Children Adults
,2 years 2–16 years Total 16–65 years .65 years Total
No. of cases 31 38 69 101 83 184
Infected joint:
Knee 35.5% 35% 35% 45% 53% 49%
Hip 38.7% 32.4% 35.5% 12.6% 15% 13.7%
Shoulder 6.5% 0% 2.9% 5.8% 13.8% 9.5%
Ankle 9.7% 16.2% 13.2% 10.6% 5.7% 8.4%
Hands and feet 0 7.9% 4.3% 11.9% 8.4% 10.3%
Other 9.6% 8.5% 9.0% 14.1% 4.1% 9.0%
Iatrogenic infections 0% 2.7% 1.5% 42% 40% 41.8%
Admission data:
Temperature (uC) 38.1 38.1 38.1 38.0 38.0 38.0
Peripheral blood:
WBC (6109/litre) 13.6 10.5 11.9 11.6 9.5 10.7
ESR (mm/h) 52 28 35 54 80 68
CRP (mg/litre) 48 38 44 125 189 125
Culture positive 23% 24% 24% 28% 41% 35%
Synovial fluid:
WBC (6106/litre) 107 100 65 900 72 600 50 000 58 400 52 700
Gram stain positive 35% 35% 35% 46% 52% 49%
Culture positive 45% 62% 54% 87% 81% 84%
Normal admission values:
Temperature ,37.8uC 19% 26% 23% 41% 44% 42%
WBC ,106109/litre 6% 43% 26% 36% 57% 46%
ESR ,20 mm/h 8% 26% 18% 18% 7% 12%
CRP ,10 mg/litre 9% 11% 7% 12% 18% 15%
Median values for WBC, ESR, CRP and temperature are shown.
CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; WBC, white blood cell count.
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utmost importance to avoid unnecessary infectious complica-
tions and to perform arthrocentesis according to the best
standard of practice.
In our study 17,9% of SA in adults occurred post-arthrocent-
esis, which is alarmingly high compared to the frequency of
1.9–3% in previous studies.4 6 7 It has been suggested that intra-
articular steroid17 or hyaluronan18 injection may increase the risk
of joint infection. Thus, the generally increased use of steroids
and hyaluronans in Iceland (table 2) may explain the increased
incidence of SA in Iceland.
Presumably organisms frequently enter the joint during
arthrocentesis. Skin fragments introduced into the joint during
arthrocentesis contained bacterial genes (by polymerase chain
reaction) one third of the time.19 and despite standard
sterilisation of the skin surface, organisms could be cultured
from needle tips in 14–28% of events.20 The best standard of
practice for arthrocentesis has not been thoroughly studied and
method of sterilisation varies considerably among doctors;21
alcohol swabs, pivodone iodine and chlorhexidine have been
used in different reports, all apparently with satisfactory results,
although chlorhexidine arguably has the edge over the other
two methods. Chlorhexidine resulted in better sterilisation of
needle tips compared to alcohol swabs20 and chlorhexidine use
yielded significantly lower skin pathogen contamination of
blood cultures compared with pivodone iodine.22 It may also be
of practical importance in the clinical settings that full
bacteriocidal effects from pivodone iodine takes over 1 min to
develop.22 As far as we know, all three types of antiseptic
techniques are in use in Iceland but no survey has been
conducted to assess their prevalence among doctors. We were
not able to correlate the type of antiseptic technique used to the
rate of SA in this retrospective study. Irrespective of this, a panel
of experts from the American College of Rheumatology
emphasised that intra-articular corticosteroid injections are
‘‘safe and effective when administered by an experienced
doctor’’.23 This may indeed be the most important factor in
avoiding iatrogenic SA following arthrocentesis.
The clinical characteristics of SA have been previously
reported in children24–28 adults,3–6 in the elderly;29–32 and
numerous reviews have been published on septic arthritis.33–36
Most previous studies in adults have been derived from selected
regions or populations, although one report represented a whole
communal region.5 The current report is the first study
reporting a nationwide survey. We screened all microbiology
laboratories in Iceland for positive joint fluid cultures, and all
hospitals in Iceland for ICD-9 and-10 discharge diagnoses of
bacterial arthritis. Our study has numerous clinical and
laboratory findings similar to previous reports. Thus, the sex
ratio of 1.7 (male/female), risk factors (including advancing
age, RA, osteoarthritis (OA), DM, iatrogenic illness), joint
involvement and pathogens cultured are quite comparable to
these reports. In our study, the frequency of polyarticular
involvement among adults was quite low (3.3%) compared to
8.4–19.5% in other studies7 8 and mortality among adults was
only 2.7%, considerably lower than reported in most studies,3–6 19
although similar to some.29 Our study agrees with previous
findings that markers of systemic inflammation (fever, leukocy-
tosis, elevated ESR or CRP) can be normal on presentation in SA.
In fact normal temperature, WBC count, ESR and CRP were
observed in 42%, 46%, 12% and 15%, respectively, in adults
(table 3). Furthermore, although SA is usually associated with
high synovial leukocyte count we observed counts less than
20 000 in 15% of adult cases. Our study emphasises the
importance of obtaining blood cultures as well as synovial fluid
cultures, and highlights the potential for false negative results if
the patient has received oral antibiotics prior to obtaining
cultures. Thus, the diagnosis of SA in adults according to our
study should primarily be derived from thorough medical history
and physical examination, supported by joint fluid WBC analysis
and confirmed by synovial/blood cultures in 88% cases.
Antibiotic exposure prior to synovial culture may decrease the
culture yield to 63%.
Surprisingly, 39% of children with clinical picture of septic
arthritis had negative synovial fluid and blood cultures. The
clinical and laboratory characteristics were similar in culture
positive and negative children. These results are identical to
numerous other reports24–28 and to date no reasonable explana-
tion has been put forward.
In summary, the incidence of septic arthritis has markedly
increased in recent years due to increased number of arthros-
copies and therapeutic joint injections. Although the frequency
of SA per procedure has not changed, these results emphasise
the importance of sterile technique and firm indications for
diagnostic and therapeutic joint procedures.
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